Oxford Biomedica

(OXB)
Sector: Pharmaceuticals & Biotechnology
417.00p
-3.00p -0.71
Last updated: 11:22:01

Share information

Name Oxford Biomedica
Epic OXB
Isin GB00BDFBVT43
Index MID300
Industry Pharmaceuticals & Biotechnology

Key numbers

Latest share price 417.00p Net gearing n/a
Market capitalisation £441.70 Debt ratio n/a
Shares in issue 100.01 Debt-to-equity ratio n/a
P/E ratio n/a Assets / equity ratio n/a
Total dividends per share n/a Price to book value n/a
Dividend yield n/a ROCE -11.69
Dividend cover n/a EPS growth n/a
Earning per share -41.29 52-week high / low 166.80p / 445.00p

Dividends

Type Ex-date Pay-date Net-dividend
No dividends declared

Contact details

Company name Oxford Biomedica
Address Windrush Court, Transport Way, Oxford, United Kingdom, OX4 6LT
Telephone +44 (0) 1865 783 000
Website http://www.oxb.com/

Directors

Director Position
Dr Frank Mathias CEO
Mr Stuart Paynter CFO
Mr Peter Soelkner Non-Executive Director
Dr Michael Hayden Non-Executive Director
Mr Robert Ghenchev Non-Executive Director
Mr Dame Kay Davies Senior Independent Director
Mr Stuart Henderson Vice Chairman
Dr Roch Doliveux Chairman and CEO
Ms Namrata P Patel Independent Non-Executive Director
Ms Catherine Moukheibir Independent Non-Executive Director
Dr Heather Preston Independent Non-Executive Director
Ms Leone Patterson Independent Non-Executive Director

Company financials

Assets £ (m) 2022 2021 2020
Reporting date 31/12/22 31/12/21 31/12/20
Intangible asssets and goodwill 105.89 0.05 0.07
Investments and other non-current assets n/a n/a n/a
Total non-current assets 244.68 73.39 75.98
Inventory / work in progress 12.62 9.52 6.91
Trade and other receivables 61.57 44.75 53.93
Cash and equivalents 141.28 108.94 46.74
Other current assets and asset held for resale 0.02 0.63 0.37
Total of all assets 460.18 237.23 183.93
Liabilities £ (m) 2022 2021 2020
Short term liabilities 59.66 33.31 52.45
Long term liabilities 164.32 16.58 18.73
Other liabilites / pension etc n/a n/a n/a
Total of all liabilities 223.99 49.89 71.18
Net assets £ (m) 2022 2021 2020
Net assets 236.19 187.34 112.75
Equity £ (m) 2022 2021 2020
Share capital 48.13 43.09 41.16
Minority interests 31.54 n/a n/a
Retained earnings -198.54 -165.81 -188.72
Share premium account 379.95 307.77 258.02
Total equity 236.19 187.34 112.75
Income £ (m) 2022 2021 2020
Turnover n/a n/a n/a
Operating profit -30.22 20.77 -5.69
Pre-tax profit -45.98 19.88 -6.57